Cornercap Investment Counsel Inc Charles River Laboratories International, Inc. Transaction History

Cornercap Investment Counsel Inc

$329 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$164.52 - $238.84 $67,782 - $98,402	-412 Reduced 22.32%	1,434 $338,000
Q3 2023 Nov 13, 2023	BUY	$194.44 - $217.61 $39,860 - $44,610	205 Added 12.49%	1,846 $361,000
Q2 2023 Aug 11, 2023	BUY	$183.71 - $210.25 $38,027 - $43,521	207 Added 14.44%	1,641 $345,000
Q1 2023 May 11, 2023	SELL	$191.89 - $259.92 $6,524 - $8,837	-34 Reduced 2.32%	1,434 $289,000
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $1,277 - $1,753	7 Added 0.48%	1,468 $289,000
Q1 2022 May 10, 2022	BUY	$255.51 - $362.11 $6,898 - $9,776	27 Added 1.88%	1,461 $415,000
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $4,099 - $5,041	-11 Reduced 0.76%	1,434 $592,000
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $67,953 - $85,851	-231 Reduced 13.78%	1,445 $535,000
Q1 2021 May 13, 2021	SELL	$249.67 - $299.48 $2.79 Million - $3.34 Million	-11,161 Reduced 86.94%	1,676 $486,000
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $785,436 - $893,769	3,538 Added 38.05%	12,837 $1.96 Million
Q3 2020 Nov 13, 2020	SELL	$175.56 - $226.45 $90,062 - $116,168	-513 Reduced 5.23%	9,299 $2.11 Million
Q2 2020 Aug 13, 2020	SELL	$118.84 - $189.72 $527,174 - $841,597	-4,436 Reduced 31.13%	9,812 $1.71 Million
Q1 2020 May 11, 2020	SELL	$98.9 - $178.34 $58,746 - $105,933	-594 Reduced 4.0%	14,248 $1.8 Million
Q4 2019 Feb 14, 2020	BUY	$126.05 - $152.76 $17,899 - $21,691	142 Added 0.97%	14,842 $2.27 Million
Q3 2019 Nov 14, 2019	SELL	$125.07 - $143.67 $18,760 - $21,550	-150 Reduced 1.01%	14,700 $1.95 Million
Q2 2019 Aug 14, 2019	SELL	$123.4 - $148.55 $6,787 - $8,170	-55 Reduced 0.37%	14,850 $2.11 Million
Q1 2019 May 15, 2019	SELL	$104.82 - $146.73 $73,374 - $102,711	-700 Reduced 4.49%	14,905 $2.17 Million
Q4 2018 Feb 14, 2019	SELL	$105.09 - $137.23 $25,747 - $33,621	-245 Reduced 1.55%	15,605 $1.77 Million
Q3 2018 Nov 14, 2018	SELL	$112.11 - $134.54 $114,352 - $137,230	-1,020 Reduced 6.05%	15,850 $2.13 Million
Q2 2018 Aug 14, 2018	SELL	$102.37 - $117.25 $18,426 - $21,105	-180 Reduced 1.06%	16,870 $1.89 Million
Q1 2018 May 15, 2018	SELL	$98.19 - $115.2 $27,493 - $32,256	-280 Reduced 1.62%	17,050 $1.82 Million
Q4 2017 Feb 14, 2018	BUY	$100.43 - $118.09 $22,094 - $25,979	220 Added 1.29%	17,330 $1.9 Million
Q3 2017 Nov 14, 2017	BUY	$96.72 - $109.26 $1.65 Million - $1.87 Million	17,110	17,110 $1.85 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

Vanguard Group Inc Valley Forge, PA

6.1M
Shares

$1.19 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$996 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

3.74M
Shares

$732 Million
0.13% of portfolio
State Street Corp Boston, MA

2.13M
Shares

$417 Million
0.02% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.94M
Shares

$380 Million
0.87% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.96B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.

Account